Blood Reviews
Volume 17, Issue 1 , Pages 33-41, March 2003

Structural basis of the fibrinogen–fibrin transformation: contributions from X-ray crystallography

  • Russell F Doolittle

      Affiliations

    • Corresponding Author InformationCorrespondence to: Russell F. Doolittle, Center for Molecular Genetics, University of California, San Diego, La Jolla, CA 92093-0634, USA. Tel.: +858-534-4417; Fax: +858-534-4985

Center for Molecular Genetics, University of California, San Diego, La Jolla, CA, USA

Abstract 

During the past several years, a number of crystal structures have been determined of fragments from fibrinogen and fibrin and, most recently, a structure of a native fibrinogen. One feature of the fibrinogen molecule that has emerged from these studies has to do with its “loose ends,” segments of the molecule that are extremely mobile and not discernable by X-ray crystallography. Some, if not all, of this flexibility is functionally important. Small synthetic peptides based on mobile parts of fibrinogen exposed by the action of thrombin have contributed significantly to these studies and may yet prove useful therapeutically. In the end, although crystal structures have added greatly to our understanding of fibrin formation, much still needs to be unraveled about how clots form.

Keywords:  fibrinogen, fibrin, crystal structures, clots

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Abbreviations: GPR-, Gly-Pro-Arg-derivatives; GPRPam, Gly-Pro-Arg-Pro-amide; GHRPam, Gly-His-Arg-Pro-amide; t-PA, tissue plasminogen activator.

PII: S0268-960X(02)00060-7

Blood Reviews
Volume 17, Issue 1 , Pages 33-41, March 2003